The Consumption of Beef on Appetite and Cognitive Function
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02614729 |
Recruitment Status :
Completed
First Posted : November 25, 2015
Results First Posted : July 8, 2019
Last Update Posted : July 8, 2019
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
The purpose of the main study is to determine whether the daily consumption of protein-rich meals containing high quality, lean beef products improves appetite control and cognitive function during a weight maintenance diet.
The purpose of the sub-study is to determine whether the daily consumption of protein-rich meals containing the same amount of high quality, lean beef products improves appetite control and cognitive function during a modest energy restriction, weight loss diet.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Obesity Poor Glycemic Control Dietary Interventions | Other: Standard Protein-Plant, Even Distribution (SP-PLANT-EVEN) Other: Standard Protein-Beef, Even Distribution (SP-BEEF-EVEN) Other: High Protein-Beef, Even Distribution (HP-BEEF-EVEN) Other: High Protein-Beef, Uneven Distribution (HP-BEEF-UNEVEN) | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 35 participants |
Allocation: | Randomized |
Intervention Model: | Crossover Assignment |
Masking: | Single (Participant) |
Primary Purpose: | Prevention |
Official Title: | A Randomized Controlled Feeding, Crossover Trial to Assess the Appetitive and Cognitive Effects of Daily Beef Consumption in Healthy, Overweight Women |
Study Start Date : | January 2014 |
Actual Primary Completion Date : | May 2015 |
Actual Study Completion Date : | May 2015 |
Arm | Intervention/treatment |
---|---|
Experimental: Energy Balance Comparison
Participants will randomly consume 4 eucaloric diets for 7 consecutive days/treatment. Energy levels for all diets are established according to needs for energy balance. Interventions: Standard Protein-Plant, Even Distribution (SP-PLANT-EVEN); Standard Protein-Beef, Even Distribution (SP-BEEF-EVEN); High Protein-Beef, Even Distribution (HP-BEEF-EVEN); High Protein-Beef, Uneven Distribution (HP-BEEF-UNEVEN) |
Other: Standard Protein-Plant, Even Distribution (SP-PLANT-EVEN)
Diet contains all plant proteins. Meals are evenly distributed throughout the day. Other: Standard Protein-Beef, Even Distribution (SP-BEEF-EVEN) Diet contains combination of beef and plant proteins. Meals are evenly distributed throughout the day. Other: High Protein-Beef, Even Distribution (HP-BEEF-EVEN) Diet contains combination of beef and plant proteins. Meals are evenly distributed throughout the day. Other: High Protein-Beef, Uneven Distribution (HP-BEEF-UNEVEN) Diet contains combination of beef and plant proteins. Meals are unevenly distributed throughout the day. |
Experimental: Energy Restriction Comparison
Participants will randomly consume 3 energy restriction diets (1250 kcal/day) for 7 consecutive days/treatment. Energy levels for all diets are established according to needs for energy restriction. Interventions: Standard Protein-Plant, Even Distribution (SP-PLANT-EVEN); Standard Protein-Beef, Even Distribution (SP-BEEF-EVEN); High Protein-Beef, Even Distribution (HP-BEEF-EVEN) |
Other: Standard Protein-Plant, Even Distribution (SP-PLANT-EVEN)
Diet contains all plant proteins. Meals are evenly distributed throughout the day. Other: Standard Protein-Beef, Even Distribution (SP-BEEF-EVEN) Diet contains combination of beef and plant proteins. Meals are evenly distributed throughout the day. Other: High Protein-Beef, Even Distribution (HP-BEEF-EVEN) Diet contains combination of beef and plant proteins. Meals are evenly distributed throughout the day. |
- Daily Energy Intake: Total Daily Intake [ Time Frame: 5 months ]Energy intake during breakfast, lunch, dinner, and evening snacks of each day 7 testing day (separated by 3-4 weeks) will be measured.
- Perceived Fullness [ Time Frame: 5 months ]Questionnaires assessing fullness will be completed throughout each of the 12-hour testing days (which are separated by 3-4 weeks). The questionnaires contain validated visual analog scales (VAS) incorporating a 100 mm horizontal line rating scale for each response. The scale is 0 to 100mm. The questions are worded in the following manner "how strong is your feeling of" with anchors of "not at all" (indicated at 0 mm) to "extremely" (indicated at 100 mm). All measures are reported at area under the curve for 0 to 630 min.
- Reaction Time as a Measure of Cognitive Performance Assessed Using the Stroop Test [ Time Frame: 5 months ]Cognitive function will be assessed during each of the 12-hour testing days using CNS Vital Signs, a validated computerized assessment. This system contains a core battery of tasks. Reaction Time is the outcome of interest measured with the Stroop Test. In the first part, the words RED, YELLOW, BLUE, & GREEN (printed in black) appear at random on the screen, & the participant presses the space bar as soon as the test subject sees the word. In the second part, the words RED, YELLOW, BLUE, & GREEN appear on the screen, printed in color. The participant is asked to press the space bar when the color of the word matches what the word says. In the third part, the words RED, YELLOW, BLUE, & GREEN appear on the screen, printed in color. The participant is asked to press the space bar when the color of the word does not match what the word says. Reaction time is in milliseconds.
- Perceived Alertness [ Time Frame: 5 months ]Alertness will be assessed during each of the 12-hour testing days (which are separated by 3-4 weeks) using the Profile of Mood States 2nd Edition (POMS2) with sub-categories of perceived vigor. POM2 is a self-report measure that allows for the quick assessment of transient, fluctuating feelings, and enduring affect states. There are 35 items. Items are rated on a 5-point Likert scale ranging from 0 (not at all) to 4 (extremely). The Alertness (Vigor-Activity) scale score indicates the extent to which individual felt alert (vigorous and/or energetic); the higher are her positive feelings and/or energy, the greater is her score (i.e., a low score indicates relatively fewer positive feelings and/or low energy). Ratings on this scale yielded a T-score of 25 (95% CI =18-32), which is ranked at the 1st percentile, and falls within the Very Low score range. The T scores were then used to calculate area under the curve.
- Perceived Hunger [ Time Frame: 5 months ]Questionnaires assessing hunger will be completed throughout each of the 12-hour testing days (which are separated by 3-4 weeks). The questionnaires contain validated visual analog scales (VAS) incorporating a 100 mm horizontal line rating scale for each response. The scale is 0 to 100mm. The questions are worded in the following manner "how strong is your feeling of" with anchors of "not at all" (indicated at 0 mm) to "extremely" (indicated at 100 mm). All measures are reported at area under the curve for 0 to 630 min.
- Perceived Prospective Food Consumption [ Time Frame: 5 months ]Questionnaires assessing prospective food consumption will be completed throughout each of the 12-hour testing days (which are separated by 3-4 weeks). The questionnaires contain validated visual analog scales (VAS) incorporating a 100 mm horizontal line rating scale for each response. The scale is 0 to 100mm. The questions are worded in the following manner "how strong is your feeling of" with anchors of "not at all" (indicated at 0 mm) to "extremely" (indicated at 100 mm). All measures are reported at area under the curve for 0 to 630 min.
- Perceived Desire to Eat [ Time Frame: 5 months ]Questionnaires assessing desire to eat will be completed throughout each of the 12-hour testing days (which are separated by 3-4 weeks). The questionnaires contain validated visual analog scales (VAS) incorporating a 100 mm horizontal line rating scale for each response. The scale is 0 to 100mm. The questions are worded in the following manner "how strong is your feeling of" with anchors of "not at all" (indicated at 0 mm) to "extremely" (indicated at 100 mm). All measures are reported at area under the curve for 0 to 630 min.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 52 Years (Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Women
- Ages: 18-52 y
- BMI: 25-32 kg/m2
- No metabolic, hormonal, and/or neural conditions/diseases that influence metabolism, appetite, or cognition
- No blood donations to American Red Cross within past 6 months
- No medication that would influence directly appetite or cognition
- No change in any medications (over the past 3 months)
- Non-smoking (for the past year)
- Not pregnant within the past 6 months (or planning to become pregnant during study)
- Have not given birth and/or lactating within the past 6 months
- Normal menstrual cycles between 26-32 days in duration; 5 menstrual cycles within the past 6 months; or able to provide documentation of oral/hormonal contraceptive use which contains low-dose estrogen/progesterone to maintain continuous levels throughout the 28-day cycle (i.e., no placebos)
- Not clinically diagnosed with an eating disorder
- No weight loss/gain (≥10 lb. in the past 6 months)
- No past history of surgical interventions for the treatment of obesity
- No allergies and/or aversions to the study foods, particularly beef
- Consumes ≤ 800 mg caffeine/day
- Of this, ≤260 mg caffeine is consumed prior to lunch (~12 oz. Starbucks coffee)
- Not currently and/or previously on a specific diet including high protein, vegan, vegetarian, etc.
- Willing and able to consume all study foods
- Habitually consumes breakfast, lunch, and dinner >4 days/week
- No history of drug abuse or alcohol abuse (i.e., >14 drinks/week; 1 drink=12 oz. beer; 5 oz. wine; 1.5 oz. liquor)
- Displays a score of <4 on the Three Factor Eating Habits Questionnaire (TFEQ)
- Conventional (typical) and consistent sleep patterns
- awake hours somewhere between 5 am - 11 pm with no afternoon naps
- rates quality of sleep as Fairly to Very Good on the Pittsburg Sleep Quality Index (PSQI)
- averages ≥ 6 sleep hours/night over the past month
- Displays a Profile of Mood State 2nd Edition (POMS2; 60-item) Depression-Dejection Scale score within 1.5 SD of the age, gender, and racial-specific normative mean (Nyenhuis et al., 1999; Petterson K et al., 2006)
- Obtained a "Yes" on the validity indicator and displayed a score of >70 (>2%) on the CNS Vital Signs Battery
- Sedentary (i.e., limited purposeful physical activity)
- Willing and able to maintain current inactivity patterns throughout the study
- Willing and able to follow all study procedures
- Generally healthy, as assessed from the medical history questionnaire
Exclusion Criteria:
- Men
- Ages: <18 or >52 y
- BMI: <25 or >32 kg/m2
- Any metabolic, hormonal, and/or neural conditions/diseases that influence metabolism, appetite, or cognition
- Have donated blood to American Red Cross within past 6 months
- Medication that would influence directly appetite or cognition
- Change in medications (over the past 3 months)
- Have smoked in the past year
- Pregnant within the past 6 months (or planning to become pregnant during study)
- Have given birth and/or lactating within the past 6 months
- Abnormal menstrual cycles [not between 26-32 days in duration; or not 5-6 menstrual cycles within the past 6 months; or not able to provide documentation of oral/hormonal contraceptive use which contains low-dose estrogen/progesterone to maintain continuous levels throughout the 28-day cycle (i.e., no placebos)]
- Clinically diagnosed with an eating disorder
- Weight loss/gain (≥10 lb. in the past 6 months)
- Past history of surgical interventions for the treatment of obesity
- Allergies and/or aversions to the study foods, particularly beef
- Consumes > 800 mg caffeine/day
- Or, of caffeine consumed, >260 mg caffeine is consumed prior to lunch (~12 oz. Starbucks coffee)
- Currently and/or previously on a specific diet including high protein, vegan, vegetarian, etc.
- Unwilling and/or unable to consume all study foods
- Habitually consumes breakfast, lunch, and dinner <4 days/week
- History of drug abuse or alcohol abuse (i.e., >14 drinks/week; 1 drink=12 oz. beer; 5 oz. wine; 1.5 oz. liquor)
- Displays a score of >4 on the Three Factor Eating Habits Questionnaire (TFEQ)
- Unconventional (atypical) and/or inconsistent sleep patterns
- awake hours not somewhere between 5 am - 11 pm and/or afternoon naps
- does not rate quality of sleep as Fairly to Very Good on the Pittsburg Sleep Quality Index (PSQI)
- averages < 6 sleep hours/night over the past month
- Does not display a Profile of Mood State 2nd Edition (POMS2; 60-item) Depression-Dejection Scale score within 1.5 SD of the age, gender, and racial-specific normative mean (Nyenhuis et al., 1999; Petterson K et al., 2006)
- Did not obtain a "Yes" on the validity indicator and/or did not display a score of >70 (>2%) on the CNS Vital Signs Battery
- Not sedentary (i.e., purposeful physical activity)
- Unwilling and/or unable to maintain current inactivity patterns throughout the study
- Unwilling and/or unable to follow all study procedures
- Not generally healthy, as assessed from the medical history questionnaire

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02614729
Principal Investigator: | Heather J Leidy, PhD | University of Missouri-Columbia |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Heather Leidy, Assistant Professor, University of Missouri-Columbia |
ClinicalTrials.gov Identifier: | NCT02614729 |
Other Study ID Numbers: |
0039674 |
First Posted: | November 25, 2015 Key Record Dates |
Results First Posted: | July 8, 2019 |
Last Update Posted: | July 8, 2019 |
Last Verified: | April 2019 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
High Protein Satiety Appetite Control Protein Distribution |
Cognitive Function Ad libitum Food Intake Obesity prevention Obesity treatment |
Obesity Overnutrition Nutrition Disorders Overweight Body Weight |